2024 Research Report | Antipsychotic Drugs Market Poised for Significant Growth by 2030, Advances in Mental Health Treatment Drive Demand
October 14, 2024 12:09 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Antipsychotic Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...
Tardive Dyskinesia (TD) Market Research 2024: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access
September 03, 2024 04:58 ET
|
Research and Markets
Dublin, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The "Tardive Dyskinesia (TD) Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has been...
Global Schizophrenia Drugs Market Report 2024: A $10+ Billion Industry by 2032 Driven by Government and Private Sector Initiatives, & Improved Diagnostic and Treatment Facilities
August 06, 2024 04:11 ET
|
Research and Markets
Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "Global Schizophrenia Drugs Market Report by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Treatment (Injectable,...
Global Anxiety Disorder Treatment Analysis Report 2024: Market to Surpass $12 Billion by 2030 - Consumer Preference for Non-Pharmacological Treatments Drives Adoption of Alternative Therapies
July 17, 2024 10:21 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Anxiety Disorder Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Neurological Disorder Drugs Market is expected to reach a revenue of USD 103.8 Bn by 2033, at 5.1% CAGR: Dimension Market Research
May 06, 2024 11:15 ET
|
Dimension Market Research
New York, May 06, 2024 (GLOBE NEWSWIRE) -- Overview The Global Neurological Disorder Drugs Market size is expected to reach USD 66.4 billion by 2024 and is further anticipated to reach USD...
Autistic Disorder Pipeline Insight Report 2024, Featuring Key Products Tasimelteon, Cariprazine, L1-79, JZP541, AB-2004, RO6953958 and SB-121
April 22, 2024 11:10 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Autistic Disorder - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...
Schizophrenia Treatment Advances with Emerging Pipeline Insights Through 2024
February 29, 2024 11:01 ET
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Schizophrenia - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. This report confers a rich, panoramic view of...
Global Schizophrenia Treatment Market Report Sheds Light on Evolution and Innovations until 2031: Focus on Atypical Antipsychotics and High-Growth Regions
January 31, 2024 10:26 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Schizophrenia Drugs Market Forecasted at $9.46 Billion by 2030, Driven by the Rising Focus on Injectable Treatments and Second-Generation Therapeutics
January 31, 2024 09:42 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Schizophrenia Drugs Market, Size, Global Forecast Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis"...
Unlocking Insights into Obsessive-Compulsive Disorder (OCD) Market: A Comprehensive Analysis and Forecast (2019-2032)
September 18, 2023 04:23 ET
|
Research and Markets
Dublin, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The "Obsessive-Compulsive Disorder - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...